DLX5 and cancer: The GSVA results for DLX5 showed that the activity of multiple signaling pathways, metabolic pathways, and neural system development pathways was upregulated (Figure 6A and Figure S10A), indicating that DLX5 accelerates the metabolic cycle in the cancer microenvironment by upregulating metabolic pathways, helping cancer cells to better grow and develop.